FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Info Collection Revision on NDA Form

Federal Register notice: FDA sends to OMB an information collection revision entitled Applications for FDA Approval To Market a New Drug 21 CFR Part ...

latest-news-card-1
Medical Devices

Medfusion Syringe Pump Recalled Over Software

Smiths Medical ASD recalls its Medfusion model 3500 syringe pump due to software-related issues that can cause the device to fail to deliver therapy.

latest-news-card-1
Human Drugs

sNDA for Ozempic Planned for Kidney Disease

Novo Nordisk says it will file a supplemental NDA this year seeking an expanded label for Ozempic (semaglutide) for preventing progression of kidney i...

Human Drugs

FDA Approves Sandoz Prolia, Xgeva Biosimilars

FDA approves Sandoz Jubbonti and Wyost, the first interchangeable biosimilars for Amgens Prolia and Xgeva.

latest-news-card-1
FDA General

Budget Compromise Gives FDA $160 Million Boost

Senate and House appropriators post a joint spending bill agreement for fiscal year 2024 that would provide FDA with a $160 million (2.4%) budget boos...

latest-news-card-1
Medical Devices

1st OTC Continuous Glucose Monitor Cleared

FDA clears a Dexcom 510(k) for the companys Stelo Glucose Biosensor System, which the agency says is the first over-the-counter continuous glucose mon...

latest-news-card-1
Federal Register

Info Collection on FDA Drug Communications

Federal Register notice: FDA sends to OMB an information collection extension entitled Data to Support Drug Product Communications as Used by the Food...

latest-news-card-1
Human Drugs

Bell Intrnatl. Labs Warned Over CGMP Violations

FDA warns Eagan, MN-based Bell International Laboratories about CGMP violations in its production of finished drugs.

latest-news-card-1
Human Drugs

CGMP Violations Found at Colgin

FDA warns Dallas, TX-based Colgin, Inc., about CGMP violations in its production of finished drugs.

latest-news-card-1
Medical Devices

QS, MDR Violations at Fresenius Kabi Facility

FDA warns Fresenius Kabi USA about QS and MDR issues at its North Andover, MA, facility that manufactures and distributes the Ivenix Infusion System.